{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T17:21:51Z","timestamp":1777915311680,"version":"3.51.4"},"reference-count":21,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Palliative Medicine"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Pheochromocytoma is a tumor arising from adrenomedullary chromaffin cells. Five-year survival with malignant pheochromocytoma is &lt;50%. Difficulty arises when prescribing for patients, given the potential to precipitate catecholamine crisis, a life-threatening emergency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Case:<\/jats:title>\n                    <jats:p>A 60-year-old woman presented with abdominal fullness and discomfort. Liver biopsy confirmed pheochromocytoma. Upper and lower abdominal pain was noted and described as \u201cdragging\u201d and \u201csharp\u201d in nature. The Endocrine Society Clinical Practice guideline for management of pheochromocytoma recommends avoidance of morphine and codeine. Subcutaneous fentanyl was tolerated with good effect, and a continuous subcutaneous infusion was commenced. She was transitioned to a fentanyl patch and her pain was controlled.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Symptom control in patients with pheochromocytoma remains challenging. Common opioid analgesics, dopamine-receptor antagonists, corticosteroids, and tricyclic antidepressants are medications known to precipitate a crisis. There is a lack of published research to support the safe prescribing of medications for these patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/jpm.2022.0402","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T14:01:51Z","timestamp":1672322511000},"page":"878-881","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Palliative Symptom Management in Malignant Pheochromocytoma: Safe Use of Fentanyl and a Review of Medications Used"],"prefix":"10.1177","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2496-9276","authenticated-orcid":false,"given":"Elaine","family":"Cunningham","sequence":"first","affiliation":[{"name":"Department of Palliative Medicine, Marymount University Hospice and Hospital, Cork, Ireland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashling","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Cork University Hospital, Cork, Ireland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Gregg","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, Marymount University Hospice and Hospital, Cork, Ireland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domhnaill J.","family":"O'Halloran","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Cork University Hospital, Cork, Ireland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aoife","family":"Lowney","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, Marymount University Hospice and Hospital, Cork, Ireland."},{"name":"Department of Palliative Medicine, Cork University Hospital, Cork, Ireland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,6,2]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1498"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e3181ebb4f0"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1053\/ejso.2002.1413"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13434"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12324"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnab019"},{"issue":"1","key":"e_1_3_3_8_2","first-page":"93","article-title":"WHO guidelines for the use of analgesics in cancer pain","volume":"7","author":"Ventafridda V","year":"1985","unstructured":"Ventafridda V, , Saita L, , Ripamonti C, et al. WHO guidelines for the use of analgesics in cancer pain. Int J Tissue React, 1985; 7(1):93\u201396.","journal-title":"Int J Tissue React"},{"key":"e_1_3_3_9_2","unstructured":"Wilcock A Howard P Charlesworth S. Chapter 1 Gastro-intestinal system. In: Palliative Care Formulary 7th ed. (Wilcock A Howard P eds.) Pharmaceutical Press: London; 2021; p. 39."},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2007.11.002"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730110-00004"},{"key":"e_1_3_3_12_2","unstructured":"Electronic Medicines Compendium (EMC) Summary of Product Characteristics. Electronic Medicines Compendium (EMC): United Kingdom; September 15 2020. Available from: Morphine10mg\/5mlOralSolution-SummaryofProductCharacteristics(SmPC)-(emc)(medicines.org.uk) [Last accessed: March 24 2022]."},{"key":"e_1_3_3_13_2","doi-asserted-by":"crossref","unstructured":"British National Formulary (BNF). Morphine. November 10 2021. Available from; https:\/\/doi.org\/10.18578\/BNF.761904314 [Last accessed: March 26 2022].","DOI":"10.18578\/BNF.761904314"},{"key":"e_1_3_3_14_2","first-page":"432","volume-title":"Chapter 5 Analgesics","author":"Wilcock A","unstructured":"Wilcock A, , Howard P, , Charlesworth S. Chapter 5 Analgesics. In: Palliative Care Formulary, 7th ed. (Wilcock A, Howard P, eds.) Pharmaceutical Press: London; 2021; pp. 432\u2013434."},{"issue":"3","key":"e_1_3_3_15_2","first-page":"543","article-title":"A practice approach to children with phaeochromocytomas and paragangliomas","volume":"24","author":"Strauss L.","year":"2018","unstructured":"Strauss L. A practice approach to children with phaeochromocytomas and paragangliomas. South Afr J Anaesth Analg, 2018; 24(3):543\u2013548.","journal-title":"South Afr J Anaesth Analg"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/62.6.616"},{"key":"e_1_3_3_17_2","first-page":"March","article-title":"Phaemochromocytoma: Perioperative Management Anaesthesia Tutorial of the Week 151. World Federation of Societies of Anaesthesiologists: Scotland; 2009","author":"Sasidharan P","unstructured":"Sasidharan P, , Johnston I. Phaemochromocytoma: Perioperative Management Anaesthesia Tutorial of the Week 151. World Federation of Societies of Anaesthesiologists: Scotland; 2009. Available from: PHAEOCHROMOCYTOMA: PERIOPERATIVE MANAGEMENT ANAESTHESIA TUTORIAL OF THE WEEK, 151: WFSA\u2014Resources (wfsahq.org) [Last accessed: March 29, 2022].","journal-title":"Available from: PHAEOCHROMOCYTOMA: PERIOPERATIVE MANAGEMENT ANAESTHESIA TUTORIAL OF THE WEEK"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.4103\/0970-9185.161665"},{"key":"e_1_3_3_19_2","unstructured":"Wilcock A Howard P Charlesworth S. Medicines Complete. Pharmaceutical Press: London."},{"key":"e_1_3_3_20_2","unstructured":"Medicines & Healthcare products Regulatory Agency. Benzodiazepines. MHRA; 2015. Available from: 3.1SedationandotheradverseCNSeffects|LearningModulesforContinuousProfessionalDevelopment(mhra.gov.uk) [Last accessed: November 8 2022]."},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2001.01082.x"},{"key":"e_1_3_3_22_2","first-page":"5930","article-title":"Light-intensity Activity-related Nausea: An Unusual Presentation of Pheochromocytoma","volume":"11","author":"Saowapa S","year":"2019","unstructured":"Saowapa S, , Rattananon P, , Sriphrapradang C. Light-intensity Activity-related Nausea: An Unusual Presentation of Pheochromocytoma. Cureus J Med Sci, 2019; 11:5930; doi: 10.7759\/2Fcureus.5930","journal-title":"Cureus J Med Sci"}],"container-title":["Journal of Palliative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jpm.2022.0402","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jpm.2022.0402","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jpm.2022.0402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:16:49Z","timestamp":1777655809000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jpm.2022.0402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1089\/jpm.2022.0402"],"URL":"https:\/\/doi.org\/10.1089\/jpm.2022.0402","relation":{},"ISSN":["1096-6218","1557-7740"],"issn-type":[{"value":"1096-6218","type":"print"},{"value":"1557-7740","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]}}}